FIELD: organic chemistry, antibiotics, pharmacy.
SUBSTANCE: invention relates to a new crystalline nonsolvated form of 40-O-(2-hydroxy)-ethylrapamycin that shows crystalline lattice with the following parameters: a = 14.37Å; b = 11.24Å; c = 18.31 Å, and volume value is 2805Å. Also, invention relates to a method for preparing this crystalline form that involves crystallization of 40-O-(2-hydroxy)ethylrapamycin from a solvent with mixture with aliphatic hydrocarbon of the formula CnH2n+2 wherein n = 5, 6 or 7. Also, invention relates to a pharmaceutical composition based on thereof and its using in preparing medicinal agents used in treatment or prophylaxis of organ or tissue transplant rejection, autoimmune, inflammatory states, asthma, proliferative disorders, tumor or hyperproliferative vascular diseases. Invention provides preparing the novel crystalline nonsolvated form of 40-O-(2-hydroxy)ethylrapamycin possessing immunosuppressive properties.
EFFECT: improved preparing method, improved and valuable medicinal properties of compound and composition.
7 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
STABILIZATION OF MACROLIDES | 1999 |
|
RU2243769C2 |
PHARMACEUTICAL COMPOSITION, USING CARBOXYLIC ACID FOR STABILIZING MACROLIDE IN THIS COMPOSITION AND METHOD FOR STABILIZING MACROLIDE | 1995 |
|
RU2292887C2 |
PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159107C2 |
MICROEMULSION PRECONCENTRATE | 1995 |
|
RU2181054C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE | 2002 |
|
RU2322970C2 |
PRELIMINARY PREPARED EMULSION CONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDE | 1999 |
|
RU2235554C2 |
DERIVATIVES OF RAPAMYCIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2158267C2 |
COMPOSITION FOR TOPICAL USE | 1995 |
|
RU2181592C2 |
PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203058C2 |
APPLICATION OF RAPAMYCIN DERIVATIVES IN VASOPATHY AND XENOTRANSPLANTATION | 1997 |
|
RU2214247C2 |
Authors
Dates
2005-11-20—Published
1999-12-06—Filed